Market cap
$183.021 M
$1.94 -4.68%
Close of 6 Nov 2026
As of 6 Nov 2026, Compugen (CGEN) has a market capitalization of $183.0M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$72.8M
#2589 by revenue
Earnings
$35.3M
#1680 by earnings
Shares outstanding
94,553,191
Latest filing cover page
P/E ratio
5.2
Cap ÷ net income
Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap
All 163 →- #96Palisade BioPALI$202.2M
- #97Inhibikase TherapeuticsIKT$201.6M
- #98CompugenCGEN$183.0M
- #99InvivydIVVD$171.6M
- #100Innate PharmaIPHA$156.4M
What if Compugen were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Compugen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.